We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Dermatology Patient Page |

Bullous Pemphigoid FREE

Misha Rosenbach, MD; Karolyn A. Wanat, MD; Cassio Lynm, MA
[+] Author Affiliations

Misha Rosenbach, MD, Section Editor

More Author Information
JAMA Dermatol. 2013;149(3):382. doi:10.1001/jamadermatol.2013.112.
Text Size: A A A
Published online

Bullous pemphigoid is an autoimmune disease, which means that the cells in the body that normally fight infection attack the body instead. The body's immune system is confused and makes an antibody (type of protein used to fight infection) that targets a part of the skin that normally holds it together. The attack on the skin causes blisters (firm, fluid-filled bubbles on the skin) to form. This disease most often involves only the skin, but the eyes, mouth, and genitals also can be affected. In most cases, the disease develops on its own, but certain medications also can cause bullous pemphigoid to develop.

Bullous pemphigoid commonly affects people older than 60 years but can occur in younger people. Once someone is diagnosed as having this disease, they can have it for many years. Treatment helps to control the disease, but there is no permanent cure.


Severe itching and blisters occur in almost all patients. Early in the course of the disease, some patients may not have blisters but instead have only a rash that looks similar to hives. These hivelike spots can be all over the body; many times, when blisters appear, they will appear on top of this rash. Blisters will sometimes break, and the exposed skin can be raw and painful. Scars usually do not develop, and the skin can return to normal, although darker spots may remain after the blisters go away. You cannot spread it to people around you (it is not contagious).


Your physician will get information from you, look at your skin, take blood, and perform skin biopsies. A skin biopsy requires a small needle injection of numbing medicine (anesthesia) and then removal of a small piece of skin (often about the size of a pencil eraser).


Treatments help control the itch and blisters and help the skin heal. The treatment will depend on how much of your skin is involved. If only a small area of skin is affected, creams applied to the skin may be enough. If a large area is involved, then oral steroids, a medicine that suppresses the immune system, and other medicines are necessary. Oral steroids help the skin but can have a number of adverse effects that require monitoring.


International Pemphigus and Pemphigoid Foundation
British Association of Dermatologists


To find this and other JAMA Dermatology Patient Page articles, go to the JAMA Dermatology Patient Page link on theJAMA Dermatology website at http://www.jamaderm.com.


Source: International Pemphigus and Pemphigoid Foundation and British Association of Dermatologists




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Pemphigoid gestationis: a successful preventive treatment by rituximab. J Eur Acad Dermatol Venereol Published online Sep 8, 2016;